Business Description
Rhelion Life Sciences Corp
NAICS : 312310
SIC : 3741
ISIN : CA75671E1097
Share Class Description:
XCNQ:RHEL: Ordinary SharesCompare
Compare
Traded in other countries / regions
RELH.CanadaTRUFF.USA4YX0.Germany IPO Date
2020-05-28Description
Rhelion Life Sciences Corp is a pharmaceutical research and development company focused on the discovery and development of natural psychedelic medicines for psychiatric and neurological conditions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.38 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -1.99 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.1 | |||||
3-Year EBITDA Growth Rate | -4.6 | |||||
3-Year FCF Growth Rate | 19.1 | |||||
3-Year Book Growth Rate | -25.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.37 | |||||
9-Day RSI | 36.77 | |||||
14-Day RSI | 39.77 | |||||
3-1 Month Momentum % | -33.33 | |||||
6-1 Month Momentum % | 100 | |||||
12-1 Month Momentum % | -14.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.98 | |||||
Quick Ratio | 3.71 | |||||
Cash Ratio | 2.9 | |||||
Days Inventory | 135.46 | |||||
Days Sales Outstanding | 46.01 | |||||
Days Payable | 108.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | 2.38 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.93 | |||||
Operating Margin % | -98.33 | |||||
Net Margin % | -145.46 | |||||
EBITDA Margin % | -161 | |||||
FCF Margin % | -86.94 | |||||
OCF Margin % | -57.74 | |||||
ROE % | -39.93 | |||||
ROA % | -32.75 | |||||
ROIC % | -61.57 | |||||
3-Year ROIIC % | -13.12 | |||||
ROC (Joel Greenblatt) % | -128.8 | |||||
ROCE % | -45.64 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 8.33 | |||||
PEG Ratio | 2.38 | |||||
PS Ratio | 2.5 | |||||
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 0.83 | |||||
EV-to-EBIT | -0.98 | |||||
EV-to-EBITDA | -1.04 | |||||
EV-to-Revenue | 1.66 | |||||
EV-to-FCF | -2.6 | |||||
Price-to-GF-Value | 0.63 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.5 | |||||
Price-to-Graham-Number | 0.63 | |||||
| Price-to-Net-Current-Asset-Value | 1.25 | |||||
| Price-to-Net-Cash | 1.25 | |||||
Earnings Yield (Greenblatt) % | -102.35 | |||||
FCF Yield % | -23.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhelion Life Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 4.195 | ||
| EPS (TTM) (C$) | -0.005 | ||
| Beta | 0.4645 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.39 | ||
| Volatility % | 106.09 | ||
| 14-Day RSI | 39.77 | ||
| 14-Day ATR (C$) | 0.004979 | ||
| 20-Day SMA (C$) | 0.028875 | ||
| 12-1 Month Momentum % | -14.29 | ||
| 52-Week Range (C$) | 0.015 - 0.05 | ||
| Shares Outstanding (Mil) | 595.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rhelion Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rhelion Life Sciences Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rhelion Life Sciences Corp Frequently Asked Questions
What is Rhelion Life Sciences Corp(XCNQ:RHEL)'s stock price today?
The current price of XCNQ:RHEL is C$0.03. The 52 week high of XCNQ:RHEL is C$0.05 and 52 week low is C$0.02.
When is next earnings date of Rhelion Life Sciences Corp(XCNQ:RHEL)?
The next earnings date of Rhelion Life Sciences Corp(XCNQ:RHEL) is .
Does Rhelion Life Sciences Corp(XCNQ:RHEL) pay dividends? If so, how much?
Rhelion Life Sciences Corp(XCNQ:RHEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Rhelion Life Sciences Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers